Published in AIDS on December 01, 1996
Voluntary HIV counselling and testing among men in rural western Uganda: implications for HIV prevention. BMC Public Health (2008) 3.21
Opt-out provider-initiated HIV testing and counselling in primary care outpatient clinics in Zambia. Bull World Health Organ (2011) 1.54
Time for oncologists to opt in for routine opt-out HIV testing? JAMA (2010) 1.53
Factors related to female sex workers' willingness to utilize VCT service: a qualitative study in Jinan city, northern China. AIDS Behav (2008) 1.42
Acceptance of Voluntary Counselling, Testing and Treatment for HIV Among Pregnant Women in Kumasi, Ghana. Ghana Med J (2008) 1.41
Acceptance of HIV testing during prenatal care. Perinatal Guidelines Evaluation Project. Public Health Rep (2001) 1.29
Implementing and evaluating a regional strategy to improve testing rates in VA patients at risk for HIV, utilizing the QUERI process as a guiding framework: QUERI Series. Implement Sci (2008) 1.27
Interpreting and implementing the 2006 CDC recommendations for HIV testing in health-care settings. Public Health Rep (2007) 1.20
Factors associated with utilization of a free HIV VCT clinic by female sex workers in Jinan City, Northern China. AIDS Behav (2011) 1.17
Personal, cognitive, behavioral, and demographic predictors of HIV testing and STDs in homeless women. J Behav Med (2000) 1.17
Characteristics and trends of newly identified HIV infections among incarcerated populations: CDC HIV voluntary counseling, testing, and referral system, 1992-1998. J Urban Health (2001) 1.15
Opt-out testing for stigmatized diseases: a social psychological approach to understanding the potential effect of recommendations for routine HIV testing. Health Psychol (2009) 1.06
Seasonal variation in undiagnosed HIV infection on the general medicine and trauma services of two urban hospitals. J Gen Intern Med (2005) 0.91
HIV status determination among tuberculosis patients from California during 2008. J Public Health Manag Pract (2013) 0.90
Voluntary counseling and testing among post-partum women in Botswana. Patient Educ Couns (2006) 0.87
Increasing the reach of HIV testing to young Latino MSM: results of a pilot study integrating outreach and services. J Health Care Poor Underserved (2009) 0.86
Poor-quality health services and lack of programme support leads to low uptake of HIV testing in rural Mozambique. Afr J AIDS Res (2012) 0.85
A mixed methods approach to identifying factors related to voluntary HIV testing among injection drug users in Shanghai, China. Int J Infect Dis (2012) 0.84
Voluntary HIV counseling and testing of pregnant women--an assessment of compliance with Michigan public health statutes. MedGenMed (2004) 0.83
Are VA primary care providers aware of HIV testing recommendations for Veterans? Findings at an urban VA primary care clinic. Mil Med (2013) 0.80
Routine testing for blood-borne viruses in prisons: a systematic review. Eur J Public Health (2015) 0.78
Determinants of antepartum human immunodeficiency virus testing in a non-Medicaid obstetric population. Infect Dis Obstet Gynecol (1998) 0.78
HIV Testing as a Standard of Care for Men Who Have Sex With Men: Patient and Provider Perspectives. J Prim Care Community Health (2011) 0.75
AIDS in black and white: the influence of newspaper coverage of HIV/AIDS on HIV/AIDS testing among African Americans and White Americans, 1993-2007. J Health Commun (2014) 0.75
Factors influencing uptake of voluntary counselling and testing services for HIV/AIDS in the Lower Manya Krobo Municipality (LMKM) in the Eastern Region of Ghana: a cross-sectional household survey. J Health Popul Nutr (2015) 0.75
Temporal trends in reasons for and result of HIV-testing among women in Rome, Italy. Eur J Epidemiol (1998) 0.75
HIV testing and retesting for men and women in Switzerland. Eur J Epidemiol (2000) 0.75
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med (1998) 53.26
Intersecting epidemics--crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team. N Engl J Med (1994) 6.01
The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals. Am J Public Health (2001) 5.32
Long-term HIV-1 infection without immunologic progression. AIDS (1994) 3.41
Comparison of plasmid profile analysis, phage typing, and antimicrobial susceptibility testing in characterizing Salmonella typhimurium isolates from outbreaks. J Clin Microbiol (1984) 3.33
Are we headed for a resurgence of the HIV epidemic among men who have sex with men? Am J Public Health (2001) 3.27
Drug-resistant Salmonella from animals fed antimicrobials. N Engl J Med (1984) 3.26
Herpes zoster and human immunodeficiency virus infection. J Infect Dis (1992) 3.04
Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force. N Engl J Med (1993) 2.91
Serum beta 2-microglobulin and prediction of progression to AIDS in HIV infection. Lancet (1992) 2.79
Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS (2001) 2.73
Aeromonas hydrophila and Plesiomonas shigelloides as causes of intestinal infections. Rev Infect Dis (1984) 2.71
Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med (1992) 2.63
HIV infection in women in the United States: status at the Millennium. JAMA (2001) 2.51
Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS (1996) 2.49
Staphylococcal food poisoning in the United States. New facts and old misconceptions. JAMA (1984) 2.35
Combination antiretroviral therapy and recent declines in AIDS incidence and mortality. J Infect Dis (1999) 2.34
Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: a prospective cohort study of human immunodeficiency virus infection in US women. Am J Epidemiol (1997) 2.32
Increased incidence of Hodgkin disease in homosexual men with HIV infection. Ann Intern Med (1992) 2.26
Is chronic hepatitis B being undertreated in the United States? J Viral Hepat (2010) 2.24
Aeromonas intestinal infections in the United States. Ann Intern Med (1986) 2.03
Sexual transmission efficiency of hepatitis B virus and human immunodeficiency virus among homosexual men. JAMA (1990) 2.00
Streptococcal pharyngitis and acute rheumatic fever in Rhode Island. JAMA (1983) 1.96
Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody. N Engl J Med (1988) 1.94
Animal-to-man transmission of antimicrobial-resistant Salmonella: investigations of U.S. outbreaks, 1971-1983. Science (1984) 1.85
Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: immunologic and virologic characteristics. J Infect Dis (1991) 1.77
The association between cigarette smoking and selected HIV-related medical conditions. AIDS (1996) 1.72
Promoting early HIV diagnosis and entry into care. AIDS (1999) 1.68
CDC's Model Performance Evaluation Program: assessment of the quality of laboratory performance for HIV-1 antibody testing. Public Health Rep (1990) 1.66
An overview of the effectiveness and efficiency of HIV prevention programs. Public Health Rep (1995) 1.62
The HIV antibody test: why gay and bisexual men want or do not want to know their results. Public Health Rep (1987) 1.62
Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet (1993) 1.50
Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients. HIV Med (2005) 1.49
Analytic sensitivity and specificity of enzyme immunoassay results in testing for human immunodeficiency virus type 1 antibody. Arch Pathol Lab Med (1992) 1.42
The relation between nitrite inhalants, unprotected receptive anal intercourse, and the risk of human immunodeficiency virus infection. Am J Epidemiol (1992) 1.36
Duration of human immunodeficiency virus infection before detection of antibody. Lancet (1989) 1.35
The effect of group education on improving attitudes about AIDS risk reduction. N Y State J Med (1987) 1.32
Plesiomonas enteric infections in the United States. Ann Intern Med (1986) 1.32
Informational privacy and the public's health: the Model State Public Health Privacy Act. Am J Public Health (2001) 1.32
Crack cocaine smokers who turn to drug injection: characteristics, factors associated with injection, and implications for HIV transmission. The Multicenter Crack Cocaine and HIV Infection Study Team. Drug Alcohol Depend (1996) 1.31
The global distribution of human immunodeficiency virus type 2 (HIV-2) infection. Transfusion (1988) 1.24
Cancer incidence in women with or at risk for HIV. Int J Cancer (2001) 1.23
Heterosexual transmission of human immunodeficiency virus type 1 from transfusion recipients to their sex partners. J Acquir Immune Defic Syndr (1994) 1.22
Decision-making in HIV prevention community planning: an integrative review. J Community Health (2000) 1.22
Sacrococcygeal teratomas: a review of 68 cases. Cancer (1981) 1.21
Epidemiologic characteristics of blood donors with antibody to human immunodeficiency virus. Transfusion (1988) 1.18
Prevention of HIV infection in street-recruited injection drug users. The Collaborative Injection Drug User Study (CIDUS). J Acquir Immune Defic Syndr (2000) 1.18
Adherence to antiretroviral medications in an inner-city population. J Acquir Immune Defic Syndr (1999) 1.17
Human immunodeficiency virus counseling, testing, referral, and partner notification services. A cost-benefit analysis. Arch Intern Med (1993) 1.16
Changing conditions and treatments in a dynamic cohort of ambulatory HIV patients: the HIV outpatient study (HOPS). Ann Epidemiol (1999) 1.09
Presence of human immunodeficiency virus (HIV) type 1, group M, non-B subtypes, Bronx, New York: a sentinel site for monitoring HIV genetic diversity in the United States. J Infect Dis (2000) 1.09
Epidemics in perspective. J Med Humanit Bioeth (1987) 1.03
Epidemic cholera in Mali: high mortality and multiple routes of transmission in a famine area. Epidemiol Infect (1988) 1.01
Indirect immunofluorescence test performance and questionnaire results from the Centers for Disease Control Model Performance Evaluation Program for human immunodeficiency virus type 1 testing. J Clin Microbiol (1990) 1.00
Human immunodeficiency virus type 2 infection in the United States. Epidemiology, diagnosis, and public health implications. JAMA (1992) 0.99
Primary care physicians and their HIV prevention practices. AIDS Patient Care STDS (1996) 0.98
Testing for antibodies to human immunodeficiency virus type 2 in the United States. MMWR Recomm Rep (1992) 0.97
Surgical practice in hospitals: HIV and the surgical team. Bull Am Coll Surg (1990) 0.97
Foodborne transmission of cholera in Micronesian households. Lancet (1984) 0.97
Cofactors for HIV disease progression in a cohort of homosexual and bisexual men. J Acquir Immune Defic Syndr (2001) 0.96
AIDS surveillance and health education: use of previously described risk factors to identify high-risk homosexuals. Am J Public Health (1984) 0.96
Vibrio fluvialis and Vibrio furnissii isolated from a stool sample of one patient. J Clin Microbiol (1984) 0.95
APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS). J Viral Hepat (2014) 0.95
Cum hastis sic clypeatis: the turbulent history of the condom. Bull N Y Acad Med (1988) 0.94
Factors related to seroconversion among homo- and bisexual men after attending a risk-reduction educational session. AIDS (1989) 0.94
HIV-specific IgG in cervicovaginal secretions of exposed HIV-uninfected female sexual partners of HIV-infected men. AIDS Res Hum Retroviruses (2001) 0.92
Urban rape survivors: characteristics and prevalence of human immunodeficiency virus and other sexually transmitted infections. Multicenter Crack Cocaine and HIV Infection Study Team. Obstet Gynecol (1995) 0.90
Intestinal anisakiasis. Report of a case and recovery of larvae from market fish. Am J Clin Pathol (1981) 0.90
Treatment options for vulvovaginal candidiasis, 1993. Clin Infect Dis (1995) 0.89
Concordance of polymerase chain reaction with human immunodeficiency virus antibody detection. J Infect Dis (1990) 0.89
Changes in HIV and AIDS epidemiology from new generation antiretroviral therapy. AIDS (1999) 0.89
Temporal trends of opportunistic infections and malignancies in homosexual men with AIDS. J Infect Dis (1994) 0.87
Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy. HIV Med (2006) 0.86
Year one of HIV prevention community planning: a national perspective on accomplishments, challenges, and future directions. J Public Health Manag Pract (1996) 0.85
New and newer enteric pathogens: stages in our knowledge. Am J Public Health (1984) 0.85
Multiple pulmonary lesions in a patient treated with BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) for glioblastoma multiforme. Cancer (1979) 0.84
Pneumocystis carinii pneumonia incidence and chemoprophylaxis failure in ambulatory HIV-infected patients. HIV Outpatient Study (HOPS) Investigators. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.84
HIV seroconversion and oral intercourse. Am J Public Health (1991) 0.84
Discontinuation of chemoprophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection. HIV Outpatient Study (HOPS) Investigators. Ann Intern Med (2000) 0.83
Cost-effectiveness of HIV-prevention skills training for men who have sex with men. AIDS (1997) 0.82
HIV/AIDS in nonurban Alabama: risk activities and access to services among HIV-infected persons. South Med J (1999) 0.82
Perspectives on HIV/AIDS epidemiology and prevention from the Eighth International Conference on AIDS. Am J Public Health (1992) 0.82
Defending HIV seroprevalence surveys. Am J Public Health (1994) 0.79
Herpesviruses as co-factors in AIDS. Lancet (1988) 0.79
Errors in reporting seropositivity for infection with human immunodeficiency virus (HIV) Ann Intern Med (1988) 0.79
The association of clinical conditions and serologic tests with CD4+ lymphocyte counts in HIV-infected subjects without AIDS. AIDS (1991) 0.79
Opportunities to improve prevention and services for HIV-infected women in nonurban Alabama and Mississippi. J Acquir Immune Defic Syndr (2001) 0.78
Comparison of clinical manifestations of HIV infection among women by risk group, CD4+ cell count, and HIV-1 plasma viral load. HER Study Group. HIV Epidemiology Research. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 0.78
Preventive services guidelines for primary care clinicians caring for adults and adolescents infected with the human immunodeficiency virus. Arch Fam Med (1993) 0.78
CD4+ T-lymphocyte counts among seronegative heterosexual partners of persons infected with human immunodeficiency virus type 1. J Acquir Immune Defic Syndr (1993) 0.77
Preventing HIV infection in gay and bisexual men: experimental evaluation of attitude change from two risk reduction interventions. AIDS Educ Prev (1990) 0.77
ANA testing: a comparison of two kits and a discussion of specificity and sensitivity as criteria for selection of screening procedures. Am J Clin Pathol (1984) 0.77
Circuit parties: sexual behaviors and HIV disclosure practices among men who have sex with men at the White Party, Palm Springs, California, 2003. AIDS Care (2006) 0.77
Histologic changes in previously irradiated thyroid glands. Arch Pathol Lab Med (1980) 0.77
Combination antiretroviral therapy and incidence of AIDS-related malignancies. J Acquir Immune Defic Syndr (1999) 0.76
Possible bias of ascertainment in assessing chemoprophylaxis for cryptosporidiosis. AIDS (2001) 0.75
Sentinel surveillance for HIV-2 infection in high-risk US populations. Am J Public Health (1993) 0.75
Are human immunodeficiency virus test reports clear to clinicians? JAMA (1990) 0.75
Herpes simplex virus type 2 and HIV seroconversion. J Acquir Immune Defic Syndr (1991) 0.75